Yatsen Holding Limited (YSG) PESTLE Analysis

Yatsen Holding Limited (YSG): PESTLE Analysis [Nov-2025 Updated]

CN | Consumer Cyclical | Specialty Retail | NYSE
Yatsen Holding Limited (YSG) PESTLE Analysis

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Yatsen Holding Limited (YSG) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

You need a clear, actionable breakdown of the external forces defintely shaping Yatsen Holding Limited (YSG)'s prospects right now. The regulatory environment in China, especially the implementation of the Cosmetic Supervision and Administration Regulation (CSAR), is the single biggest near-term risk, but the consumer shift to premiumization offers a significant opportunity if executed correctly. We're talking about navigating a regulatory minefield while chasing a market that could redefine their margins, so let's dig into the Political, Economic, Sociological, Technological, Legal, and Environmental factors shaping YSG's 2025 outlook.

Yatsen Holding Limited (YSG) - PESTLE Analysis: Political factors

You are operating in a political landscape that is both a tailwind and a headwind right now. The Chinese government's core economic strategy strongly favors domestic champions like Yatsen Holding Limited, but this support comes with a non-negotiable requirement for stricter product safety and advertising compliance. You need to be thinking of government policy not just as a risk, but as a direct, actionable product development mandate.

Increased scrutiny from China's State Council on C-Beauty market practices.

The central government's focus on quality and consumer protection has fundamentally changed the operational cost of doing business in the C-Beauty (Chinese Beauty) sector. The National Medical Products Administration (NMPA) is the primary enforcement body, and its regulatory framework is now one of the strictest globally.

The major shift came on November 17, 2025, when the NMPA released the final version of the Opinions on Deepening Cosmetics Regulatory Reform and Promoting High-Quality Development of the Industry. This document introduces 24 major reform measures across five key areas. For a company like Yatsen Holding Limited, which is shifting its revenue mix to higher-margin skincare, this means significantly higher investment in R&D and compliance to validate efficacy claims.

Here's the quick math on compliance: new NMPA rules, effective August 1, 2025, require enhanced safety risk monitoring. This means a larger, more expensive in-house regulatory team and more rigorous third-party testing. If a new product launch is delayed by even a single quarter due to compliance issues, the lost revenue opportunity is substantial, especially considering your Q3 2025 net revenues were RMB998.4 million (US$140.2 million).

Stricter advertising content review by the National Medical Products Administration (NMPA).

The NMPA is cracking down on vague or exaggerated marketing claims, a practice that was common among fast-growing C-Beauty brands. For Yatsen Holding Limited, this is a double-edged sword: it raises your marketing compliance costs, but it also levels the playing field against smaller, less scrupulous competitors.

The new regulatory focus requires scientific evidence for all efficacy claims, particularly for high-growth categories like anti-aging and whitening. This is a direct challenge to your marketing spend, which was already significant at RMB682.3 million (US$95.8 million) in Q3 2025. You defintely need to shift that spend from influencer hype to clinical validation.

The regulatory shift is clear:

  • Pre-market Scrutiny: Stricter evaluation of efficacy claim reports before product launch.
  • Post-market Surveillance: New safety risk monitoring measures that took effect in August 2025.
  • Innovation Support: The NMPA is streamlining registration for cosmetics with new efficacies, which is an opportunity to accelerate your R&D-driven skincare brands like DR.WU and Galénic.

Government emphasis on domestic consumption (Dual Circulation strategy) favors local brands like Yatsen Holding Limited.

China's Dual Circulation strategy is a clear political mandate that favors domestic brands by prioritizing the 'internal circulation' of the economy-meaning domestic production and consumption. This policy is a huge structural advantage for Yatsen Holding Limited.

The government is actively fostering a consumption-driven economy; the World Bank projects that by 2027, over 60% of China's GDP will come from domestic consumption. Your company is perfectly positioned as a local champion to capture this growth, especially as your Skincare Brands revenue surged by 83.2% year-over-year in Q3 2025 to RMB490.8 million. This growth is a direct reflection of the policy's success and the rising preference for high-quality domestic brands (Guochao).

This political support translates into a lower customer acquisition cost relative to foreign competitors, plus better access to government-backed initiatives and distribution channels. It's a structural subsidy for domestic growth.

Geopolitical tensions between the US and China affect supply chain stability and investor sentiment.

As a Cayman Islands holding company listed on the New York Stock Exchange (NYSE: YSG), Yatsen Holding Limited is acutely exposed to US-China geopolitical risk, despite its operations being entirely China-based. The renewed threat of a potential 100% tariff on all Chinese goods in late 2025, while primarily targeting manufacturing, creates a volatile environment for US-listed Chinese stocks.

Here's the breakdown of the dual risk:

Risk Factor Impact on Yatsen Holding Limited Mitigation/Action
Investor Sentiment (NYSE) Increased volatility and lower valuation multiples due to potential delisting risk (VIE structure scrutiny) and general US-China tension. Maintain strong cash position (RMB1.16 billion in cash/short-term investments as of Q3 2025) and focus on narrowing net loss (Q3 2025 net loss narrowed by 41.9% to RMB70.4 million).
Supply Chain Stability Risk of disruption or price volatility for imported high-end raw materials and ingredients (e.g., from Europe) due to trade war ripple effects or retaliatory tariffs. Accelerate domestic sourcing and R&D for new ingredients to ensure self-sufficiency, aligning with the Dual Circulation strategy's goal of self-reliance.

The market is already pricing in geopolitical risk; your focus must be on operational resilience. Chinese companies are building parallel supply chains to overcome Western trade restrictions, and Yatsen Holding Limited should be doing the same for its high-value inputs.

Yatsen Holding Limited (YSG) - PESTLE Analysis: Economic factors

You're looking at Yatsen Holding Limited (YSG) and trying to map the economic headwinds and tailwinds for 2025. The core takeaway is this: China's slowing, but still significant, GDP growth provides a large consumer base, but intense cost pressures from raw materials and a volatile RMB/USD exchange rate are forcing Yatsen to rely heavily on its high-margin skincare portfolio to maintain profitability.

China's projected GDP growth for 2025, while slowing, still supports discretionary consumer spending.

While the pace of expansion is moderating from historical highs, China's economic engine is far from stalled. The official target and consensus forecasts for real GDP growth in 2025 hover around the 5.0% mark. For context, the GDP grew 5.2% year-on-year in the first three quarters of 2025, demonstrating resilience despite the property market drag. This growth rate is still substantial enough to expand the middle class and support discretionary spending on non-essential goods like cosmetics.

However, the growth is uneven. Domestic demand remains subdued, so Yatsen must focus on capturing a greater share of the existing consumer wallet, rather than just riding a massive boom. That's why their strategic pivot to higher-end skincare brands is smart.

Intense price competition in the mass-market beauty segment squeezes margins.

The domestic mass-market color cosmetics segment, where Yatsen's Perfect Diary brand competes, is a battlefield of price wars against both local rivals and international brands. This competition makes it difficult to raise prices, putting a ceiling on profitability for that segment.

Here's the quick math: Yatsen's overall gross margin for the third quarter of 2025 actually increased to a strong 78.2%. This improvement is a direct result of their shift, as their Skincare Brands revenue surged by 83.2% year-over-year. The Color Cosmetics Brands, while seeing a revenue increase of 25.2%, still face the brunt of the margin squeeze, meaning the high-end skincare portfolio is subsidizing the mass-market fight.

Financial Metric (Q3 2025) Value (RMB) Insight
Total Net Revenues RMB998.4 million Up 47.5% YoY, showing overall recovery.
Gross Margin 78.2% Strong, but masks lower margins in mass-market color cosmetics.
Skincare Revenue Growth (YoY) 83.2% The primary driver for margin expansion and growth.

Rising raw material and logistics costs put pressure on the cost of goods sold.

The cost of goods sold (COGS) faces pressure from two sides: raw materials and logistics. China's cosmetics industry is heavily reliant on imports for core ingredients, with approximately 80% of these sourced from Europe, the U.S., Japan, and South Korea. This dependence exposes Yatsen to global commodity price volatility and trade tariffs.

  • Raw Material Risk: Global price increases for specialized ingredients directly inflate the base cost of product formulation.
  • Logistics Cost: International freight can account for up to 15% of a product's total landed cost.
  • Tariff Impact: The ongoing trade tensions, including China's reciprocal 34% tariffs on U.S. imports, increase the cost of any U.S.-sourced ingredients or packaging components.

To be fair, Yatsen's fulfillment expenses were a manageable 5.5% of total net revenues in Q4 2024, but any further escalation in global shipping rates or tariffs will defintely push that number higher.

Currency fluctuations (RMB vs. USD) impact the cost of importing foreign-acquired brands.

Yatsen's strategy includes foreign-acquired brands like Galénic and DR.WU. Since the purchase price and ongoing sourcing for these brands are often denominated in foreign currencies (like USD or EUR), a depreciating Chinese Yuan (RMB) directly increases the cost of those imports in RMB terms, squeezing the profit on those sales.

Analysts project the USD/CNY exchange rate to remain volatile through 2025. While some forecasts see a range of 7.10 to 7.35, a new round of trade friction could push the rate to 7.40 to 7.50. UBS, for instance, anticipated the USD/CNY rate to reach 7.5 by June 2025. A move from the current approximate rate of 7.29 (as of May 2025) to 7.50 represents a depreciation of over 2.8% for the RMB, which is a direct hit to the cost of importing foreign-brand inventory.

Yatsen Holding Limited (YSG) - PESTLE Analysis: Social factors

Strong consumer shift toward 'Conscious Consumption' (ingredient safety, efficacy)

You're seeing a fundamental shift in China's beauty market: consumers are becoming 'skintellectuals,' prioritizing clinical efficacy and ingredient safety over pure brand prestige. This isn't a niche trend; it's the new baseline for product development. For Yatsen Holding Limited, this means the success of your legacy color cosmetics brands, like Perfect Diary, is increasingly tied to a scientific narrative.

The numbers are clear: 91% of Chinese consumers now actively check for active ingredients in makeup, and 76% believe in the efficacy of skincare-infused formulations (or 'makeup care'). This demand for 'functional beauty' is what's driving the market. Brands focusing on natural and holistic care are also seeing a massive tailwind, with a 314% increase in related product demand in 2024. Your move into brands like Galénic and DR.WU is defintely the right strategic pivot to capture this high-margin, science-led demand.

Rapid adoption of live-streaming commerce (Douyin, Kuaishou) as a primary sales channel

The sales floor has moved to the live stream. In China, live-streaming commerce is no longer just a marketing channel; it's a primary distribution and conversion engine, especially for fast-moving consumer goods like beauty. Total live commerce Gross Merchandise Value (GMV) is projected to hit a staggering ¥6.5 trillion (approximately $940 billion USD) in 2025.

Douyin, in particular, is the dominant player. Its beauty category GMV reached nearly ¥20 billion in July 2025, representing a 31.7% year-over-year increase. Live commerce accounts for a massive 40% of Douyin's e-commerce revenue. This is where your marketing spend needs to be laser-focused. It's instant, interactive, and addictive-a perfect fit for your digitally-native C-Beauty roots.

Live Commerce Platform Estimated Live Commerce GMV Share (2025) Key User Insight
Douyin 47% Strong blend of entertainment and shopping; 700M daily users.
Kuaishou 27% Strong presence in lower-tier cities; known for grassroots creators.
Taobao Live 23% Traditional e-commerce integration; focus on established brands.

Growing demand for high-end, efficacious skincare over color cosmetics, driving premiumization

The market is structurally shifting from discretionary makeup to essential, high-efficacy skincare, and your financials reflect this perfectly. The entire Chinese beauty and personal care market is forecast to reach $78 billion in revenue in 2025. But the real growth engine is premium skincare.

Here's the quick math from your Q2 2025 results: net revenues from your skincare brands surged by 78.7% year-over-year, and skincare now contributes 53.5% of your total revenues. This pivot is boosting your bottom line, as evidenced by your gross margin improving to 78.3% in Q2 2025, supported by these higher-margin skincare sales. The market for dermatology-grade skincare alone is expected to reach ¥850 billion by 2030, showing the long-term runway for your science-backed brands.

Younger consumers (Gen Z) exhibit low brand loyalty and high willingness to try new C-Beauty brands

Brand loyalty is on the wane, which is a significant risk for legacy brands but a massive opportunity for agile, C-Beauty (Chinese Beauty) players like Yatsen. Consumers are not sticking to a single brand; they are mixing and matching to meet specific needs. This fragmentation means you must treat every purchase as a new acquisition opportunity.

The data shows that 37% of consumers are reducing repeat purchases from previously favored brands. Gen Z, in particular, is driving demand for products tied to cultural identity and are highly willing to try new domestic brands. This is why six of the top ten beauty brands with the most market share growth in China since 2020 are Chinese. Your strategy must lean into this trend by:

  • Focusing on hyper-specific product efficacy.
  • Integrating cultural heritage into branding (Guochao).
  • Maintaining a rich brand matrix to capture fragmented demand.

The low loyalty means the cost of customer acquisition (CAC) is high, so your focus on high-margin skincare is crucial to offset the constant need to win over a fickle, but highly engaged, younger audience.

Yatsen Holding Limited (YSG) - PESTLE Analysis: Technological factors

Heavy reliance on proprietary data analytics for new product development and targeted marketing.

Yatsen Holding Limited's core business model is built on being a digital-first company, which means its technology stack is not a support function-it's the engine. This reliance on proprietary data analytics allows the company to rapidly identify and respond to consumer preferences, a process often called Consumer-to-Manufacturer (C2M). The strategy is working, especially in the high-growth skincare segment.

The company's strategic pivot toward higher-margin skincare brands like Galénic and DR. WU, which is heavily informed by consumer data, has paid off in 2025. Skincare revenue saw a massive 78.7% year-on-year increase in the second quarter of 2025 (Q2 2025), reaching RMB 580 million. This segment now contributes 53.5% of total revenue, a fundamental shift from its historical focus on color cosmetics. Here's the quick math: data-driven product development is directly fueling the company's primary growth curve and improving its gross margin, which rose to 78.3% in Q2 2025. You simply cannot achieve that kind of growth without deep, real-time consumer insights.

Significant investment in R&D for ingredient innovation and formulation patents is crucial.

The shift to skincare moves Yatsen from a marketing-led to a science-led business, making sustained Research and Development (R&D) investment non-negotiable. The company has committed over RMB 600 million to R&D to date, consistently maintaining spending above 3% of annual revenue. This spending is focused on ingredient innovation and building a defensible intellectual property (IP) portfolio.

In Q3 2025 alone, R&D expenses were RMB 39.8 million, representing 4% of total net revenues, a clear signal of ongoing commitment. This investment supports a global R&D network, including three centers in Shanghai, Guangzhou, and Toulouse, France. The tangible output of this focus is seen in their IP filings:

  • Total global patents filed since 2022: 252
  • Invention applications filed since 2022: 78

The goal isn't just new products; it's proprietary ingredients and formulations that justify a premium price and higher gross margin. That's a defintely smart move.

R&D Investment Snapshot (2025 Fiscal Year) Amount (RMB) As % of Total Net Revenue
Q3 2025 R&D Expenses 39.8 million 4.0%
Q2 2025 R&D Expenses 36.1 million 3.3%
Q1 2025 R&D Expenses 22.6 million (USD equivalent) 2.7%

Use of Augmented Reality (AR) and Virtual Try-On technologies to enhance the online shopping experience.

To bridge the gap between online shopping and the need to physically test makeup, Yatsen's brands, such as Perfect Diary, rely on Augmented Reality (AR) and Virtual Try-On (VTO) technology. This technology is critical for color cosmetics, where the inability to sample products online is a major friction point leading to cart abandonment and higher return rates.

The broader beauty market is seeing VTO technology grow exponentially, with the virtual makeup market expected to reach $1.12 billion in 2025. For brands that use AR, conversion rates can increase by up to 90%. Yatsen, which targets the digitally native Gen Z and Millennial consumer, must keep pace with these innovations. They use AR not just for simple color-matching but also for interactive experiences like AR gamification to drive engagement and private domain traffic, which is essential for customer retention.

Vulnerability to platform policy changes on major e-commerce sites like Alibaba's Tmall.

Despite its digital expertise, Yatsen operates as a third-party seller on China's massive e-commerce platforms, primarily Alibaba's Tmall. This reliance creates a structural vulnerability to changes in platform policy, which can shift the cost of customer acquisition overnight.

In 2025, Tmall has focused on two major shifts that directly impact Yatsen: the Trust & Authenticity 3.0 Framework and the move to an AI-First Product Discovery & Advertising Engine. The Trust framework imposes stricter documentation and anti-counterfeit measures, increasing compliance costs and operational complexity for all brands. More critically, the new AI-First engine means success is now heavily dependent on 'feeding the algorithm with rich product data, reviews, and engaging content' to achieve a strong Return on Ad Spend (ROAS). If Yatsen's data analytics team misreads the new algorithm's preferences, their marketing spend-a huge expense that was 66.4% of total net revenues in Q1 2025-could become inefficient, eroding profitability fast. Your next step is clear: model a 10% drop in ROAS on Tmall to stress-test your Q4 2025 cash flow projections.

Yatsen Holding Limited (YSG) - PESTLE Analysis: Legal factors

Full implementation of the Cosmetic Supervision and Administration Regulation (CSAR) demands rigorous product registration.

You need to understand that the Cosmetic Supervision and Administration Regulation (CSAR), which became effective back in 2021, is now fully backed by a complex web of subsidiary regulations, meaning compliance is no longer a suggestion-it's a hard requirement. The National Medical Products Administration (NMPA) has been steadily closing regulatory loopholes, making the entire product lifecycle-from ingredient sourcing to final sale-subject to intense scrutiny. This means Yatsen Holding Limited must ensure all its products, especially those with new ingredients, undergo a dual-track registration and notification process that is far more detailed than before. Simple registration is out; full-scale, documented compliance is in.

The new Administrative Measures for Monitoring and Evaluation of Cosmetic Safety Risks, which took effect on August 1, 2025, underscore this shift. These rules mandate that cosmetic companies (registrants and notifiers) must track and report safety risks, which includes checks on ingredients and finished products. This is a significant operational burden, requiring Yatsen to invest heavily in its internal quality management systems.

New requirements for mandatory efficacy testing and claims substantiation increase compliance costs.

The days of vague, marketing-driven claims are over in China's cosmetics market. The CSAR requires that all efficacy claims-like moisturizing, anti-aging, or whitening-must be substantiated with scientific, reasonable, and feasible evaluation methods. This is a non-negotiable step that demands substantial investment in R&D and third-party testing.

Here's the quick math on Yatsen's commitment to this: the Research and Development (R&D) expenses for the third quarter of 2025 were RMB39.8 million (US$5.6 million), a notable jump from RMB25.3 million in the prior year period. As a percentage of total net revenues, R&D expenses increased to 4.0% in Q3 2025 from 3.7% in the prior year period. This rise is defintely driven by the need for more rigorous testing and new product development to meet these strict efficacy standards. It's expensive, but it's the cost of credibility now.

The table below shows the direct financial impact of this regulatory push on Yatsen's R&D spending, a key proxy for compliance costs:

Metric Q3 2025 Value Q3 2024 Value Change Driver
R&D Expenses (RMB) RMB39.8 million RMB25.3 million Higher payroll from increased R&D headcount.
R&D Expenses (USD) US$5.6 million N/A N/A
R&D % of Total Net Revenues 4.0% 3.7% Directly reflects investment in efficacy testing/innovation.

Intellectual property (IP) protection challenges remain high in China for brand formulas and designs.

While China has significantly strengthened its IP laws and enforcement, the sheer volume of infringement means the challenge of protection remains high for a multi-brand group like Yatsen Holding Limited. You have to be proactive. The country's judicial system is actively involved, with Chinese courts resolving 494,000 IP-related cases in 2024 alone, and prosecutors pursuing 21,000 individuals for infringing on trademarks, patents, and business secrets. This shows a strong will to enforce, but also the scale of the problem you are up against.

For Yatsen, which relies on proprietary formulas and distinctive brand designs across its portfolio (like Perfect Diary and Little Ondine), the risk of counterfeiting and trade secret theft is continuous. Protecting your core intellectual assets-the formulas, the packaging designs, and the brand names-requires constant legal vigilance, not just a one-time filing.

  • Formulas: Must be protected as trade secrets, requiring strict internal security protocols.
  • Designs: Need continuous monitoring of e-commerce platforms for copycat products.
  • Trademarks: Essential to file for protection across all relevant classes and monitor for bad-faith registrations.

Stricter data privacy laws govern the collection and use of consumer purchasing data.

As a digital-native company relying heavily on e-commerce and direct-to-consumer (DTC) sales, Yatsen's business model is directly impacted by China's stringent data protection framework, anchored by the Personal Information Protection Law (PIPL). This law governs how you collect, process, and transfer consumer purchasing data, which is critical for your targeted marketing.

The new Network Data Security Management Regulations, effective January 1, 2025, further tighten the screws, especially for companies that handle large volumes of personal information. For a company of Yatsen's scale, which likely processes the data of more than 10 million individuals, the requirements are significant:

  • Mandatory self-initiated compliance audits of personal data processing activities must be conducted at least once every two years, starting May 1, 2025.
  • You must designate a person in charge of personal information protection (DPO).
  • Non-compliance can trigger severe penalties, including fines of up to 5% of annual revenue or RMB 50 million.

The key action here is to ensure your data collection practices-from website cookies to purchase history-are based on explicit, informed consent and that your cross-border data transfer mechanisms are fully compliant with the latest CAC (Cyberspace Administration of China) security assessment rules.

Yatsen Holding Limited (YSG) - PESTLE Analysis: Environmental factors

You need to see the environmental landscape not just as a compliance headache, but as a critical driver of consumer preference and capital allocation in 2025. Yatsen Holding Limited is ahead of the curve in China, holding an MSCI ESG Rating of A for two consecutive years as of November 2025, but global standards are moving fast. This is a non-negotiable area for investor confidence and brand equity, so let's look at the hard numbers.

Increasing consumer demand for sustainable packaging and reduced plastic use.

The market has spoken: sustainability is a premium feature, not a niche. The global cosmetic packaging market is projected to reach USD 36,801.52 million in 2025, with growth heavily driven by eco-friendly solutions. In the U.S. alone, over 65% of beauty consumers prioritize sustainable packaging, and a strong majority of consumers, 90%, are more likely to buy from brands that use it. To be fair, this is a clear opportunity to command a higher margin, as 43% of consumers are willing to pay extra for a product with sustainable packaging.

Yatsen Holding Limited has made concrete moves here, especially with its flagship brands. The focus is on material reduction and refillable systems, which is the smart play for both cost and consumer loyalty.

  • Perfect Diary's Milk Foam Makeup Remover refill bags cut plastic use by 86%.
  • The refill structure for Perfect Diary's Translucent Blurring Longwear Foundation reduces plastic by 91.6% compared to the original packaging.
  • All brands adopted Forest Stewardship Council (FSC)-certified express cartons, a key step in traceable sourcing.

Requirement for transparent reporting on carbon footprint and supply chain emissions.

The era of vague environmental claims is over; investors, regulators, and consumers demand verifiable data. This is why carbon footprint (CFP) certification is now a baseline requirement for market access, especially in Europe and for US-listed companies. Yatsen Holding Limited has been proactive, which is defintely a credit to their risk management.

The company has completed carbon audits and received a Product Carbon Footprint Certification for a Perfect Diary lipstick, making it one of the first beauty products in China to achieve this. Also, by the end of 2022, all seven of Yatsen Holding Limited's core suppliers had implemented carbon emission management protocols, a crucial step toward controlling Scope 3 emissions (value chain emissions) which are the hardest to track. This level of supply chain control is a competitive advantage in a world moving toward mandatory climate disclosures.

Waste management and disposal regulations for cosmetic products and packaging are tightening.

Regulatory pressure is mounting globally, shifting the financial burden of waste management from municipalities to producers via Extended Producer Responsibility (EPR) schemes. In the U.S., six states now have EPR laws, and in the EU, the Packaging and Packaging Waste Regulation (PPWR), which came into force in February 2025, is a game-changer. It mandates a reduction in packaging volume and weight, and requires a limit on unused space by at least 50%.

Yatsen Holding Limited is mitigating this risk by focusing on lightweighting and material substitution, as evidenced by their 2023 figures reported in 2024:

Environmental Metric (2023 Data) Brand/Product Specific Achievement
Plastic Reduction (Refill) Perfect Diary Milk Foam Makeup Remover Plastic use reduced by 86%
Plastic Reduction (Refill) Perfect Diary Translucent Blurring Longwear Foundation Plastic reduced by 91.6%
Certified Paper Use All Brands (Express Cartons) ~1,350 tonnes of carton materials from traceable forests
Eco-Friendly Fillers Galénic and EVE LOM 100% of packaging fillers use eco-friendly paper

Focus on cruelty-free testing methods to align with global ethical standards.

The ethical standard is clear: no animal testing. But the regulatory reality, particularly in the massive China market where Yatsen Holding Limited is a leading group, is still complex. While China has relaxed pre-market testing for 'general cosmetics,' imported 'special cosmetics' (like sunscreens) still face the risk of mandated animal testing in 2025, both pre- and post-market.

This creates a material risk for any brand seeking a 'cruelty-free' certification like Leaping Bunny. The EU is trying to close its own loopholes, setting a 2026 roadmap to advance non-animal testing. For Yatsen Holding Limited, the strategic action is to accelerate investment in non-animal testing methods, especially given China's National Medical Products Administration (NMPA) introduced a grace period until May 1, 2025, for companies to gather safety data, signaling an eventual move toward global non-animal testing standards. Their R&D centers and focus on scientific innovation are the right tools to navigate this regulatory tightrope.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.